Endocrinology drugs are used to treat hormonal problems such as hypothyroidism, diabetes and others.
Due to the COVID-19 pandemic, the global Endocrinology Drugs market size is estimated to be worth US$ 96820 million in 2021 and is forecast to a readjusted size of US$ 139410 million by 2028 with a CAGR of 5.3% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Endocrinology Drugs market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Endocrinology Drugs landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
One of the market drivers is increase in prevalence of endocrine hormone-related diseases.
This report focuses on Endocrinology Drugs volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Endocrinology Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Endocrinology Drugs Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Diabetes Drugs
Testosterone Replacement Drugs
Human Growth Hormone Drugs
Thyroid Hormone Disorder Drugs
Segment by Application
Hospitals
Commercial Laboratories
Ambulatory Care Centres
Other Setting
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
AbbVie
AstraZeneca
Eli Lilly
Merck
Novo Nordisk
Sanofi